Nephrocardioprotective role of the Klotho protein circulating form in patients with chronic kidney disease


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Nephro- and cardioprotective role of circulating protein Klotho is discussed.

Texto integral

Acesso é fechado

Bibliografia

  1. Добронравов В.А. Современный взгляд на патофизиологию вторичного гиперпаратиреоза: роль фактора роста фибробластов 23 и Klotho. Нефрология. 2011; 15 (4): 11—20.
  2. Милованова Л.Ю., Козловская Л.В., Милованов Ю.С. и др. Механизмы нарушения фосфорно-кальциевого гомеостаза в развитии сердечно-сосудистых осложнений у больных хронической болезнью почек. Роль фактора роста фибробластов-23 (FGF-23) и Klotho. Тер. арх. 2010; 6: 66— 72.
  3. Милованова Л.Ю., Милованов Ю.С., Добросмыслов И.А. и др. Севеламера гидрохлорид - новые перспективы в коррекции гиперфосфатемии у больных хронической болезнью почек III—V стадий. Клин. нефрол. 2012; 5—6: 49—53.
  4. Милованова Л.Ю., Милованов Ю.С., Козловская Л.В. и др. Новые маркеры кардиоренальных взаимоотношений при хронической болезни почек. Тер. архив. 2013; 6: 45— 50.
  5. Милованова Л.Ю., Милованов Ю.С., Козловская Л.В. Нарушения фосфорно-кальциевого обмена при хронической болезни почек III— V стадий. Клин. нефрол. 2011; 1: 58—68.
  6. Милованова Л.Ю., Милованов Ю.С., Плотникова А.А., Добросмыслов И.А. Эктопическая минерализация при хронической болезни почек - механизмы, патогенез, современные возможности профилактики и лечения. Современ. мед. наука. 2012; 1: 16—33.
  7. Милованова Л.Ю., Николаев А.Ю., Милованов Ю.С. Гиперфосфатемия как фактор риска сердечно-соудистых заболеваний у больных ХПН. Нефрол. и диал. 2002; 2: 113—117.
  8. Национальные рекомендации по минеральным и костным нарушениям при хронической болезни почек. Российское диализное общество (май 2010). // Нефрол. и диал. 2011; 13(1): 33—51.
  9. Шутов Е.В. Значение фактора роста фибробластов-23 у больных хронической болезнью почек - обзор современных исследований. Лечащий врач. 2012; 8: 12—18.
  10. Aizawa H., Saito Y., Nakamura T. et al. Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats. Biochemical and Biophysical Research Communications. 1998; 249(3): 865—871.
  11. Borst M.H., Vervloet M.G. Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease. Am J Soc Nephrol. 2011; 22( 9): 1603—1609.
  12. Budoff M.J., Rader M.P., Reilly M.T. et al. Relationship of Estimated GFR and Coronary Artery Calcification in the (CRIC) Chronic Renal Insufficiency Cohort Study. Am J Kidney Dis. 2011; 58(4): 519—526.
  13. Cavalli L., Mazzotta C., Brandi M.L. Phosphatonins: physiological role and pathological changes. Clin. Cases. Miner. Bone Metab. 2012; 9(1): 9-12.
  14. Chung- Yi C., Kuro-o M., Mohammed S. Razzaque Molecular Regulation of Phosphate Metabolism by Fibroblast Growth Factor-23-Klotho System. Adv Chronic Kidney Dis. 2011; 18(2): 91-97.
  15. Faul C., Amaral A.P., Oskouei B. et al. FGF23 induces left ventricular hypertrophy. Clin. J. Invest. 2011; 121(5): 4393-4408.
  16. Gutiérrez O.M., Januzzi J.L., Isakova T. et al. Fibroblast Growth Factor-23 and Left Ventricular Hypertrophy in Chronic Kidney Disease. Circulation. 2009; 119(19): 2545-2552.
  17. Gutierrez O., Isakova T., Rhee E. et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. Am J Soc Nephrol. 2005; 16(5): 2205-2215.
  18. Haruna Y., Kashihara N., Satoh M. et al. Amelioration of progressive renal injury by genetic manipulation of Klotho gene. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(7): 2331-2336.
  19. Hruska K.A., Mathew S., Lund R. Hyperphosphatemia of Chronic Kidney Disease. Kidney Int. 2008; 74(2): 148-157.
  20. Hu M.C., Shi M., Zhang J. et al. Klotho deficiency causes vascular calcification in chronic kidney disease. Am J Soc Nephrol. 2011; 22(1): 124-136.
  21. Hu M. C., Shi M., Zhang J. et al. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney International. 2010; 78(12): 1240-1251.
  22. Hu P., Xuan Q., Hu B. et al. Fibroblast Growth Factor-23 Helps Explain the Biphasic Cardiovascular Effects of Vitamin D in Chronic Kidney Disease. Biol J Sci. 2012; 8(5): 663-671.
  23. Isakova T., Wahl P., Vargas G.S. et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int. 2011; 79(5): 1370-1380.
  24. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evalution, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int. 2009; 76 (Suppl. 113): S1-S130.
  25. Koh N., Fujimori T., Nishiguchi S. et al. Severely reduced production of Klotho in human chronic renal failure kidney. Biochemical and Biophysical Research Communications. 2001; 280(4): 1015-1020.
  26. Kuro-o M. Klotho in chronic kidney disease - What's new? Nephrology Dialysis Transplant. 2009; 24(6): 1705-1708.
  27. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial. 2003; 16(2): 101-105.
  28. Maekawa Y., Ishikawa K., Yasuda O. et al. Klotho suppresses TNF-α-induced expression of adhesion molecules in the endothelium and attenuates NF-κB activation. Endocrine. 2009; 35(3): 341-346.
  29. Maltese G., Karalliedde J. The Putative Role of the Antiageing Protein Klotho in Cardiovascular and Renal Disease. Int J Hypertens. 2012; (2012): Article ID 757469
  30. Martin A., David V., Quarles L.D. Regulation and function of the FGF23/KLOTHO endocrine pathways. Physiol Rev. 2012; 92(1): 131-155.
  31. Matsumura Y., Aizawa H., Shiraki-Iida T. et al. Identification of the human Klotho gene and its two transcripts encoding membrane and secreted Klotho protein. Biochem Biophys Res Commun. 1998; 242(3): 626- 630.
  32. Middleton R.J., Parfrey P.S., Foley R.N. Left ventricular hypertrophy in the renal patient. Am J Soc Nephrol. 2001; 12: 1079-84.
  33. Milovanova L., Milovanov Y., Plotnikova A. Phosphorus and Calcium Metabolism Disorders Assosiated with Chronic Kidney Disease Stage III-IV (Systematic Rewiew and Meta-Analysis). Chronic Kidney Disease and renal Transplantation. Ed. by Manisha Sahay. INTECH. 2012: 95-118.
  34. Mirza M.A., Larsson A., Lind L. et al. Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis. 2009; 205: 385-390.
  35. Mitani H., Ishizaka N., Aizawa T. et al. In vivo Klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension. 2002; 39: 838-843.
  36. Saito Y., Nakamura T., Ohyama Y. et al. In vivo Klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochemical and Biophysical Research Communications. 2000; 276 (2): 767-772.
  37. Sarnak M.J. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis. 2003; 41: 11-17.
  38. Semba R.D., Cappola A.R., Sun K. et al. Plasma Klotho and cardiovascular disease in adults. Am J Geriatr. Soc. 2011; 59(9): 1596-1601.
  39. Sugiura H., Yoshida T., Mitobe M. et al. Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70. Nephrology Dialysis Transplantation. 2010; 25(1): 60-68
  40. Sugiura H., Yoshida T., Tsuchiya K. et al. Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrology Dialysis Transplantation. 2005; 20(12): 2636-2645.
  41. Sugiura H., Yoshida T., Mitobe M. et al. Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70. Nephrology Dialysis Transplantation. 2010; 25(1): 60-68.
  42. Wang Y. Sun Z. Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension. 2009; 54(4) 4: 810-817.
  43. Zou Y., Togao O. et al. Klotho inhibits transforming growth factor-β1 (TGF-β1) signaling and suppresses renal fibrosis and cancer metastasis in mice. Biol J Chem. 2011; 286(10): 8655- 8665.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies